Delisting riskPopularity #4,340
ISPC · NASDAQ · Medical - Diagnostics & Research

iSpecimen (ISPC)

Order-driven marketplace for annotated human biospecimens.

$1.26
After hours−0.00 (−0.31%)
At close$1.27(−4.17%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue332331110000
Cost of revenue111121100100
Gross profit111110000−100
444436223231
Research & development111111111−100
243226112121
Selling & marketing111113001121
General & administrative132114111110
Other expenses1−1111−1000200
Operating income−2−3−3−2−2−6−2−2−3−3−3−1
000000010−200
Interest income000000000000
Interest expense000000000000
Other non-operating income0000000−10200
Income before tax−2−3−3−2−1−6−2−1−3−5−2−1
Net income from continuing operations−2−3−3−2−1−6−2−1−3−5−2−1
Net income−2−3−3−2−1−6−2−1−3−5−2−1
EPS, basic−$186.40−$270.57−$254.22−$148.78−$83.82−$251.11−$28.55−$16.78−$19.05−$23.59−$6.66−$0.98
EPS, diluted−$186.40−$270.57−$254.22−$148.78−$83.82−$251.11−$28.55−$16.78−$19.05−$23.59−$6.66−$0.98
Weighted average shares, basic000000000001
Weighted average shares, diluted000000000001
EBITDA−2−2−2−1−1−5−1−1−2−5−2−1
Depreciation & amortization111111000000
EBIT−2−3−3−2−1−6−2−1−3−5−2−1